Federal update: DOJ partially rescheduled medical cannabis to Schedule III (April 28, 2026 final order). State-licensed medical operators may apply for expedited DEA registration through June 27, 2026; DEA hearing on full rescheduling set for June 29, 2026.

WV Qualifying Conditions — W. Va. Code § 16A-2-1

West Virginia’s qualifying "serious medical conditions" are enumerated in W. Va. Code § 16A-2-1: cancer; HIV/AIDS; ALS; Parkinson’s; multiple sclerosis; spinal-cord nerve damage with intractable spasticity; epilepsy; neuropathies; Huntington’s disease; Crohn’s disease; PTSD; intractable seizures; sickle cell anemia; severe chronic or intractable pain (the most-used condition statewide); and terminal illness. Opioid use disorder is NOT a standalone qualifying condition — though severe chronic pain pulls in many patients with prior opioid exposure. The list is expandable through Medical Cannabis Advisory Board (MCAB) petitions reviewed by the Office of Medical Cannabis (OMC).

Last verified: May 2026

The Statute — § 16A-2-1

The West Virginia Medical Cannabis Act, codified at W. Va. Code Chapter 16A, defines "serious medical condition" as one of an enumerated list. A West Virginia–licensed MD or DO who has completed the OMC’s mandatory 4-hour course may certify a patient for medical cannabis only if the patient has been diagnosed with one of these conditions in the course of a bona fide practitioner-patient relationship under § 16A-4-3(3).

Condition / mechanicDetail
Qualifying "serious medical conditions" — W. Va. Code § 16A-2-1
CancerAll forms
HIV/AIDS
ALS (Lou Gehrig's)
Parkinson's disease
Multiple sclerosis (MS)
Spinal-cord nerve damage with intractable spasticityObjective neurological indication required
Epilepsy
Neuropathies
Huntington's disease
Crohn's disease
PTSD
Intractable seizures
Sickle cell anemia
Severe chronic or intractable painMost-used qualifying condition statewide
Terminal illness~12-month life expectancy
OUD (opioid use disorder)NOT a standalone qualifying condition — opioid-alternative framing is implicit, not explicit
Patient mechanics
Residency proofUtility bill within 60 days, voter registration, mortgage, tax record
Age18+ direct; minors via caregiver
Certifying practitionerWV-licensed MD or DO; OMC 4-hour course required
Registered physicians (late 2025)~123 + 26 telemedicine companies
Bona fide relationshipW. Va. Code § 16A-4-3(3) — continuing care for certified condition
Application fee$50 annually; hardship waivers ≤200% federal poverty
Card validity1 year; renewable
CaregiversUp to 2 per patient (§ 16A-3-1); 1 caregiver = up to 5 patients; state + federal background check
Out-of-state reciprocityNONE — PA / OH / MD / VA cards have ZERO legal effect in WV
TelemedicinePermitted — practical necessity in rural WV (McDowell County, etc.)
Allowed formsPills, oils, topicals, vapes, dry leaf for vaporization, tinctures, liquids, transdermal patches
Prohibited formsEdibles, smokable flower (combustion), home cultivation

Source: W. Va. Code ch. 16A; West Virginia Office of Medical Cannabis (OMC), 350 Capitol Street, Room 523, Charleston, WV 25301; (304) 356-5090 / 844-949-1709; medcanwv@wv.gov; omc.wv.gov. The qualifying-condition list can be expanded through petitions reviewed by the Medical Cannabis Advisory Board (MCAB). Despite repeated advocacy, OUD remains absent — though severe chronic pain pulls in many patients with prior opioid exposure. The "no edibles" restriction makes WV one of only two medical-cannabis states with that ban (alongside Minnesota's earlier program); HB 5260 (2026) would have allowed lozenges + gelatin in geometric / non-candy shapes capped at 10 mg THC/serving but died in the Senate.

The 14+ Qualifying Conditions

  1. Cancer — all forms.
  2. HIV/AIDS.
  3. Amyotrophic lateral sclerosis (ALS / Lou Gehrig’s disease).
  4. Parkinson’s disease.
  5. Multiple sclerosis (MS).
  6. Damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity. Objective neurological indication is required — subjective complaints of stiffness alone do not qualify.
  7. Epilepsy.
  8. Neuropathies (including peripheral neuropathy from diabetes, chemotherapy, or other causes).
  9. Huntington’s disease.
  10. Crohn’s disease.
  11. Post-traumatic stress disorder (PTSD). Often used by veterans receiving care through Beckley, Clarksburg (Louis A. Johnson), Huntington (Hershel "Woody" Williams), and Martinsburg VA Medical Centers — though VA federal benefits and federal employment can be affected; see get-card.
  12. Intractable seizures.
  13. Sickle cell anemia.
  14. Severe chronic or intractable pain (including pain of neuropathic origin) — this is the most-used qualifying condition statewide. The breadth of this category is what makes WV’s program function in practice as an opioid alternative.
  15. Terminal illness — defined as life expectancy of approximately one year or less if the illness runs its normal course.

The Opioid-Alternative Implication

SB 386’s political path was opioid-framed. Sen. Richard Ojeda (D-Logan), Del. Mike Pushkin (D-Kanawha), and Marijuana Policy Project staff (notably WVU graduate Matt Simon) repeatedly told legislators that medical cannabis would offer pain patients a safer alternative to OxyContin and hydrocodone. As Simon put it after passage: "for many patients, medical marijuana is a far safer alternative to opioids and other prescription drugs."

Because severe chronic or intractable pain is a qualifying condition, in practice many West Virginia patients present pain-related diagnoses linked to prior opioid use. The program effectively functions as an off-ramp from the prescription opioid pipeline, even though "opioid use disorder" itself is not enumerated. See cannabis-as-opioid-alternative page.

Why Opioid Use Disorder Is Not Listed

Despite repeated advocacy from Mountain State Spotlight reporting, NORML West Virginia, and patient advocates, OUD has never been added as a standalone qualifying condition in West Virginia. Pennsylvania added OUD in 2018; West Virginia’s MCAB has not recommended it. Reasons include:

  • Federal Schedule I conflict for medication-assisted treatment (MAT) providers
  • Resistance from the West Virginia State Medical Association on standard-of-care grounds
  • Gov. Morrisey’s 2025-2026 opposition to expansion: per his 2024 campaign release, "I’m not for adding more drugs into our state"
  • Pediatric overdose concerns related to fentanyl exposure

In practice, OUD-affected patients with comorbid chronic pain still qualify under condition #14 (severe chronic pain).

The MCAB Expansion Path

The Medical Cannabis Advisory Board, created by SB 386 and operating under the OMC, can recommend additional qualifying conditions. Petitions are submitted to the OMC at 350 Capitol Street, Room 523, Charleston. Petitions go to the MCAB for review, and recommendations go to the Bureau Commissioner who may pursue rulemaking or seek statutory amendment. The MCAB recommended whole-plant access in 2018, which led to SB 339 (2020) adding "dry leaf or plant form" for vaporization — the most consequential expansion to date. See OMC page.

Practical Patient Pathways

For West Virginia patients evaluating eligibility:

  • Cancer patients — standard fit; oncology referrals from Charleston Area Medical Center (CAMC), WVU Cancer Institute (Morgantown), and Edwards Cancer Center at Cabell Huntington Hospital.
  • Pain patients — the broadest category; severe chronic or intractable pain (including neuropathic origin) qualifies. Patients should bring imaging, treatment history, and a documented chronicity record.
  • Veterans with PTSD — qualify under PTSD; should review federal-employment implications before certification (VA Medical Center care does not preclude state-card certification, but federal pension or clearance interactions are case-specific).
  • MS / Parkinson’s / ALS / Huntington’s — standard fit.
  • Pediatric epilepsy — minor patients access via caregiver under W. Va. Code § 16A-3-1.
  • Crohn’s disease — qualifies; gastroenterology certification accepted.

What If Your Condition Is Not Listed

If your condition is not on the § 16A-2-1 list, you cannot lawfully obtain a West Virginia medical cannabis card. Telemedicine "shops" that promise certification for non-qualifying conditions are operating outside the statute and put both patient and physician at risk. The path forward in such cases:

  • Submit a petition to add the condition through the MCAB (petitions reviewed periodically)
  • Contact your state senator or delegate (West Virginia Legislature, wvlegislature.gov) to pursue statutory addition
  • Continue to pursue conventional treatment under your physician’s direction
  • Recognize that CBD-derived from federally-compliant hemp is a separate market (West Virginia Department of Agriculture industrial hemp program); see glossary for terminology.